Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zunyi Medical Univ. EGFR L858R/T790M/C797S compound A-7
- Lead developer
- Zunyi Medical University
01
Overview
Zunyi Medical Univ. EGFR L858R/T790M/C797S compound A-7: sourced facts only. name: "Among them, compound A-7 was confirmed as a potential EGFRL858R/T790M/C797S and EGFRDel19/T790M/C797S inhibitor."; target: "Among them, compound A-7 was confirmed as a potential EGFRL858R/T790M/C797S and EGFRDel19/T790M/C797S inhibitor."; developer: "School of Bioengineering, Zunyi Medical University, Zhuhai 519041, China; Key Laboratory of Biocatalysis & Chiral Drug Synthesis of Guizhou Province, Zunyi Medical University, Zunyi 563000, China."
02
Targets
Source types: Peer-reviewed publication. Sources are available to Gosset users. Log in to see them.
Beyond the preview
Go deeper on Zunyi Medical Univ. EGFR L858R/T790M/C797S compound A-7.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zunyi Medical Univ. EGFR L858R/T790M/C797S compound A-7.
Work on Zunyi Medical Univ. EGFR L858R/T790M/C797S compound A-7? Claim this page to correct or add information. Claim this page